He Was Ordered to Kill Iranian Protesters – Now He Faces a Death...
Federal Agent Involved in Shooting Amid Anti-ICE Tensions
Did Hawaii Just Use a Racist 'Black Code' to Justify Its Gun Control...
Trump Is About to Cross Iran's Red Line – the Regime Should Be...
Democrats Will Impeach Trump If They Win in November
Guess Where Students for Justice in Palestine Is Getting Its Talking Points From
Bait and Switch: One Group Claims It's Found a Way to Occupy the...
Newsom Called Bessent 'Smug.' The Treasury Secretary Had No Issue Putting Him Back...
Harmeet Dhillon Warns Virginia: DEI Is DOA
Bari Weiss Needs to Nuke the 'Standards Held by Veteran Journalists'
Hoo Boy: CNN Panelist Issued a Retraction After Defaming President Trump Twice
Roy Cooper Attacks Health Insurers As Campaign Takes Industry Donations
Erika Kirks Turns to This Law to Speed Up the Trial of Her...
Mamdani Dodges Question on Racist Posts by Top Administration Appointees
Howard Lutnick Slams Globalization at the World Economic Forum
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos